A citation-based method for searching scientific literature

David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh, Andrew G Nicholson, Shandra L Knight, Suhail Raoof, Luca Richeldi, Christopher J Ryerson, Jay H Ryu, Athol U Wells. Lancet Respir Med 2018
Times Cited: 479







List of co-cited articles
797 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
64

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
36

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
31

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
669
29

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
25

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
23

Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Christopher J Ryerson, Jeffrey L Myers, Michael Kreuter, Martina Vasakova, Elena Bargagli, Jonathan H Chung, Bridget F Collins, Elisabeth Bendstrup,[...]. Am J Respir Crit Care Med 2020
238
18

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
670
14

Fleischner Society: glossary of terms for thoracic imaging.
David M Hansell, Alexander A Bankier, Heber MacMahon, Theresa C McLoud, Nestor L Müller, Jacques Remy. Radiology 2008
14

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
682
13

Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study.
Lauren K Troy, Christopher Grainge, Tamera J Corte, Jonathan P Williamson, Michael P Vallely, Wendy A Cooper, Annabelle Mahar, Jeffrey L Myers, Simon Lai, Ellie Mulyadi,[...]. Lancet Respir Med 2020
164
13

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
976
13

Spectrum of Fibrotic Lung Diseases.
Marlies Wijsenbeek, Vincent Cottin. N Engl J Med 2020
150
13

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
12

Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
700
12

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
12

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
657
12

Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.
Carlo Albera, Ulrich Costabel, Elizabeth A Fagan, Marilyn K Glassberg, Eduard Gorina, Lisa Lancaster, David J Lederer, Steven D Nathan, Dominique Spirig, Jeff J Swigris. Eur Respir J 2016
104
11

Interobserver variability in the CT assessment of honeycombing in the lungs.
Takeyuki Watadani, Fumikazu Sakai, Takeshi Johkoh, Satoshi Noma, Masanori Akira, Kiminori Fujimoto, Alexander A Bankier, Kyung Soo Lee, Nestor L Müller, Jae-Woo Song,[...]. Radiology 2013
219
11

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia.
Robert Brownell, Teng Moua, Travis S Henry, Brett M Elicker, Darin White, Eric Vittinghoff, Kirk D Jones, Anatoly Urisman, Carlos Aravena, Kerri A Johannson,[...]. Thorax 2017
77
12

Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation study.
Ganesh Raghu, Kevin R Flaherty, David J Lederer, David A Lynch, Thomas V Colby, Jeffrey L Myers, Steve D Groshong, Brandon T Larsen, Jonathan H Chung, Mark P Steele,[...]. Lancet Respir Med 2019
70
14

In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.
John P Hutchinson, Andrew W Fogarty, Tricia M McKeever, Richard B Hubbard. Am J Respir Crit Care Med 2016
247
10


Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
Kevin R Flaherty, Talmadge E King, Ganesh Raghu, Joseph P Lynch, Thomas V Colby, William D Travis, Barry H Gross, Ella A Kazerooni, Galen B Toews, Qi Long,[...]. Am J Respir Crit Care Med 2004
395
9

Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study.
Simon L F Walsh, Lucio Calandriello, Mario Silva, Nicola Sverzellati. Lancet Respir Med 2018
146
9

Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia.
Luca Richeldi, Mary Beth Scholand, David A Lynch, Thomas V Colby, Jeffrey L Myers, Steve D Groshong, Jonathan H Chung, Sadia Benzaquen, Steven D Nathan, J Russell Davis,[...]. Am J Respir Crit Care Med 2021
28
32

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.
Martin Kolb, Luca Richeldi, Jürgen Behr, Toby M Maher, Wenbo Tang, Susanne Stowasser, Christoph Hallmann, Roland M du Bois. Thorax 2017
136
9

Radiologic-pathologic discordance in biopsy-proven usual interstitial pneumonia.
Kunihiro Yagihashi, Jason Huckleberry, Thomas V Colby, Henry D Tazelaar, Jordan Zach, Baskaran Sundaram, Sudhakar Pipavath, Marvin I Schwarz, David A Lynch. Eur Respir J 2016
83
10

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Jürgen Behr, Antje Prasse, Michael Kreuter, Johannes Johow, Klaus F Rabe, Francesco Bonella, Reiner Bonnet, Christian Grohe, Matthias Held, Heinrike Wilkens,[...]. Lancet Respir Med 2021
99
9

Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study.
Simon L F Walsh, Athol U Wells, Sujal R Desai, Venerino Poletti, Sara Piciucchi, Alessandra Dubini, Hilario Nunes, Dominique Valeyre, Pierre Y Brillet, Marianne Kambouchner,[...]. Lancet Respir Med 2016
241
8

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
523
8

What's in a name? That which we call IPF, by any other name would act the same.
Athol U Wells, Kevin K Brown, Kevin R Flaherty, Martin Kolb, Victor J Thannickal. Eur Respir J 2018
156
8

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
553
8

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
237
8

Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis.
Sara Tomassetti, Athol U Wells, Ulrich Costabel, Alberto Cavazza, Thomas V Colby, Giulio Rossi, Nicola Sverzellati, Angelo Carloni, Elisa Carretta, Matteo Buccioli,[...]. Am J Respir Crit Care Med 2016
211
8

Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Athol U Wells, Kevin R Flaherty, Kevin K Brown, Yoshikazu Inoue, Anand Devaraj, Luca Richeldi, Teng Moua, Bruno Crestani, Wim A Wuyts, Susanne Stowasser,[...]. Lancet Respir Med 2020
187
8

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
979
8

Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up.
Stephen M Humphries, Kunihiro Yagihashi, Jason Huckleberry, Byung-Hak Rho, Joyce D Schroeder, Matthew Strand, Marvin I Schwarz, Kevin R Flaherty, Ella A Kazerooni, Edwin J R van Beek,[...]. Radiology 2017
83
9

Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT.
Simon L F Walsh, Lucio Calandriello, Nicola Sverzellati, Athol U Wells, David M Hansell. Thorax 2016
165
8

CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis.
Jonathan H Chung, Ashish Chawla, Anna L Peljto, Carlyne D Cool, Steve D Groshong, Janet L Talbert, David F McKean, Kevin K Brown, Tasha E Fingerlin, Marvin I Schwarz,[...]. Chest 2015
109
8

Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis.
M Thomeer, M Demedts, J Behr, R Buhl, U Costabel, C D R Flower, J Verschakelen, F Laurent, A G Nicholson, E K Verbeken,[...]. Eur Respir J 2008
102
7

Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference.
Roland M du Bois, Derek Weycker, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Alex Kartashov, Talmadge E King, Lisa Lancaster, Paul W Noble, Steven A Sahn,[...]. Am J Respir Crit Care Med 2011
315
7

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008.
John P Hutchinson, Tricia M McKeever, Andrew W Fogarty, Vidya Navaratnam, Richard B Hubbard. Eur Respir J 2016
100
7

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
692
7

Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.
Brett Ley, Jeffrey Swigris, Bann-Mo Day, John L Stauffer, Karina Raimundo, Willis Chou, Harold R Collard. Am J Respir Crit Care Med 2017
102
7

Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Roland M du Bois, Elizabeth A Fagan, Robert S Fishman, Ian Glaspole, Marilyn K Glassberg, Lisa Lancaster,[...]. Eur Respir J 2016
242
7

Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.
Ganesh Raghu, Athol U Wells, Andrew G Nicholson, Luca Richeldi, Kevin R Flaherty, Florence Le Maulf, Susanne Stowasser, Rozsa Schlenker-Herceg, David M Hansell. Am J Respir Crit Care Med 2017
114
7

Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey.
Gregory P Cosgrove, Pauline Bianchi, Sherry Danese, David J Lederer. BMC Pulm Med 2018
72
8

Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases.
Micaela Romagnoli, Thomas V Colby, Jean-Philippe Berthet, Anne Sophie Gamez, Jean-Pierre Mallet, Isabelle Serre, Alessandra Cancellieri, Alberto Cavazza, Laurence Solovei, Andrea Dell'Amore,[...]. Am J Respir Crit Care Med 2019
103
6

Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis.
Fabien Maldonado, Teng Moua, Srinivasan Rajagopalan, Ronald A Karwoski, Sushravya Raghunath, Paul A Decker, Thomas E Hartman, Brian J Bartholmai, Richard A Robb, Jay H Ryu. Eur Respir J 2014
141
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.